Hyderabad Telangana, India

Manohar Sarma Vedula


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Manohar Sarma Vedula

Introduction

Manohar Sarma Vedula, based in Hyderabad, Telangana, India, is a notable inventor recognized for his significant contributions to the pharmaceutical industry. With a total of two patents to his name, he has focused on improving processes related to heparin production, which is vital for various medical applications.

Latest Patents

Manohar's latest patents include a "Process for the preparation of Dalteparin sodium" and a "Process for the preparation of low molecular weight heparin." The first patent presents an improved method for synthesizing Dalteparin sodium, emphasizing simplicity, commercial viability, and industrial advantages. Similarly, his second patent details an efficient process for producing Enoxaparin sodium, also highlighting its commercial and industrial benefits.

Career Highlights

Currently, Manohar Sarma Vedula works at Biological E Limited, a prominent player in the biopharmaceutical sector. His work at this company underscores his commitment to enhancing healthcare through innovative medicinal products. Manohar's contributions in the form of patented processes not only advance the field but also improve the accessibility of essential medications.

Collaborations

Throughout his career, Manohar has collaborated with talented colleagues such as Narender Dev Mantena and Sreedhar Kosgi. Together, they contribute to a culture of innovation at Biological E Limited, driving the development of effective pharmaceutical solutions.

Conclusion

Manohar Sarma Vedula's inventive spirit and dedication to advancing pharmaceutical processes have established him as a key inventor in his field. His patents demonstrate the importance of innovation in healthcare, paving the way for improved treatments and therapies. As he continues his work at Biological E Limited, the industry can anticipate further contributions that will enhance patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…